MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.7556
-0.0005 (-0.07%)
Aug 27, 2026, 12:07 PM EDT - Market open
MDxHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 114.02 | 107.88 | 90.05 | 70.19 | 37.05 | 22.24 | |
Revenue Growth | 15.23% | 19.80% | 28.29% | 89.43% | 66.62% | 20.47% |
Cost of Revenue | 42.35 | 38.24 | 34.91 | 26.26 | 17.84 | 11.68 |
Gross Profit | 71.67 | 69.63 | 55.14 | 43.93 | 19.22 | 10.56 |
Selling, General & Admin | 78.82 | 69.49 | 63.78 | 59.93 | 49.01 | 31.37 |
Research & Development | 10.13 | 10.35 | 10.55 | 6.38 | 5.45 | 5.59 |
Amortization of Goodwill & Intangibles | 5.08 | 5.19 | 4.91 | 4.49 | 3.17 | 1.61 |
Other Operating Expenses | -0.9 | -0.99 | 0.62 | 0.46 | 0.07 | -0.12 |
Operating Expenses | 93.13 | 84.04 | 79.86 | 71.26 | 57.71 | 38.45 |
Operating Income | -21.46 | -14.41 | -24.72 | -27.33 | -38.49 | -27.88 |
Interest Expense | -8.95 | -11.62 | -7.63 | -5.58 | -2.64 | -1.88 |
Interest & Investment Income | 3.25 | 1.5 | 1.08 | 1.09 | 0.13 | 0.01 |
Other Non Operating Income (Expenses) | -0.94 | -0.94 | 0.62 | -2.12 | -0.19 | -0.1 |
EBT Excluding Unusual Items | -28.09 | -25.46 | -30.66 | -33.95 | -41.19 | -29.85 |
Asset Writedown | - | - | - | - | -0.04 | - |
Other Unusual Items | -9.92 | -9.92 | -7.03 | -9.15 | -2.81 | 0.85 |
Pretax Income | -38.01 | -35.38 | -37.69 | -43.1 | -44.04 | -29 |
Income Tax Expense | -1.58 | -1.86 | 0.38 | 0 | - | - |
Net Income | -37.34 | -33.52 | -38.07 | -43.1 | -44.04 | -29 |
Net Income to Common | -37.34 | -33.52 | -38.07 | -43.1 | -44.04 | -29 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 50 | 50 | 33 | 26 | 16 | 12 |
Shares Outstanding (Diluted) | 50 | 50 | 33 | 26 | 16 | 12 |
Shares Change | 13.74% | 52.05% | 26.82% | 63.31% | 30.12% | 46.56% |
EPS (Basic) | -0.74 | -0.67 | -1.16 | -1.66 | -2.78 | -2.38 |
EPS (Diluted) | -0.74 | -0.67 | -1.16 | -1.66 | -2.78 | -2.38 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.02 | -3.35 | -19.72 | -24.24 | -36.91 | -23.44 |
Free Cash Flow Per Share | -0.12 | -0.07 | -0.60 | -0.94 | -2.33 | -1.92 |
Gross Margin | 62.86% | 64.55% | 61.23% | 62.58% | 51.87% | 47.50% |
Operating Margin | -18.82% | -13.36% | -27.45% | -38.93% | -103.87% | -125.37% |
Profit Margin | -32.75% | -31.07% | -42.28% | -61.40% | -118.86% | -130.41% |
Free Cash Flow Margin | -5.28% | -3.10% | -21.90% | -34.54% | -99.60% | -105.42% |
EBITDA | -14.93 | -8.15 | -18.96 | -21.66 | -33.58 | -24.85 |
EBITDA Margin | -13.09% | -7.56% | -21.05% | -30.85% | -90.62% | -111.72% |
D&A For EBITDA | 6.53 | 6.26 | 5.77 | 5.67 | 4.91 | 3.04 |
EBIT | -21.46 | -14.41 | -24.72 | -27.33 | -38.49 | -27.88 |
EBIT Margin | -18.82% | -13.36% | -27.45% | -38.93% | -103.87% | -125.37% |
Revenue as Reported | - | - | - | - | - | 22.24 |